Crossref
From Trastuzumab to Trastuzumab Deruxtecan: Two Decades of Progress in HER2-Positive Advanced Breast Cancer, with a Focus on Central Nervous System Disease
Oncology Research · 2026 · 1-10
DOI: 10.32604/or.2026.090148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Monica Esteban-Garcia und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Esteban-Garcia, M., Browne, I. M., & Okines, A. F. C. (2026). From Trastuzumab to Trastuzumab Deruxtecan: Two Decades of Progress in HER2-Positive Advanced Breast Cancer, with a Focus on Central Nervous System Disease. Oncology Research, 0(0), 1-10. https://doi.org/10.32604/or.2026.090148
Vancouver
Esteban-Garcia M, Browne IM, Okines AFC. From Trastuzumab to Trastuzumab Deruxtecan: Two Decades of Progress in HER2-Positive Advanced Breast Cancer, with a Focus on Central Nervous System Disease. Oncology Research. 2026;0(0):1-10. doi:10.32604/or.2026.090148
BibTeX
@article{EstebanGarcia2026,
author = {Esteban-Garcia, Monica and Browne, Iseult M. and Okines, Alicia F. C.},
title = {From Trastuzumab to Trastuzumab Deruxtecan: Two Decades of Progress in HER2-Positive Advanced Breast Cancer, with a Focus on Central Nervous System Disease},
journal = {Oncology Research},
year = {2026},
volume = {0},
number = {0},
pages = {1--10},
doi = {10.32604/or.2026.090148}
}
EUVIMED